Xoma conducts reverse split; drug indexes slip
August 18, 2010 at 10:43 AM EDT
Shares of biotech group Xoma Ltd. spike over 1,000% at the market open, as the company conducts a 1-for-15 reverse stock split in order to boost its stock price to meet Nasdaq compliance rules.